BFM
KITE

Boothbay Fund Management’s Kite Pharma, Inc. KITE Stock Holding History

Boothbay Fund Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,400
Closed -$294K – 643
2016
Q1 		$294K Buy
+6,400
New +$310K 0.22% 148

Boothbay Fund Management's KITE Position: Q4 2017 in Review

Boothbay Fund Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 23,517 shares — an estimated $4.23M sold.

Boothbay Fund Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $4.23M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Boothbay Fund Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Boothbay Fund Management sold 23,517 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.23M.
  • Boothbay Fund Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Boothbay Fund Management's Kite Pharma, Inc. position peaked at $4.23M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Boothbay Fund Management's 13F filing for Q4 2017, filed 14 Feb 2018.